Travere Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results

Go back to Travere Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results
(NASDAQ: TVTX) Delayed: 62.76 -1.98 (3.06%)
Previous Close $64.74    52 Week High
Open $64.89    52 Week Low
Day High $64.89    P/E N/A 
Day Low $62.47    EPS
Volume 2,235,856